Trials / Terminated
TerminatedNCT03076918
Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
A Phase II Study Evaluating the Non-inferiority of the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy (PDT)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the efficacy and tolerance of a new device (FLEXITHERALIGHT) for photodynamic therapy in the treatment of keratosis actinic in comparison of classical PDT with Aktilite®.
Detailed description
The study is an intraindividual comparison of two methods. The number of subjects to be enrolled is 47 patients. All participants will receive both two treatments in a single visit : a first period of 2.5 hours of illumination with FLEXITHERALIGHT device followed by a continuous red light Spectrum (between 7 and 10 minutes) with Aktilite® after an appropriate incubation of methyl aminolevulinate). Patients will complete a pain assessment scale after receiving both treatments, then, 3 follow up visits will be scheduled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FLEXITHERALIGHT PDT | Preparation of lesions, MAL application+occlusive dressing during 30 minutes+illumination 2.5 hours |
| DEVICE | Aktilite® Galderma | Preparation of lesions, MAL application+occlusive dressing during 3 hours+illumination 7 to 10 minutes |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2017-03-10
- Last updated
- 2018-05-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03076918. Inclusion in this directory is not an endorsement.